New registry aims to unlock secrets of rare pregnancy complication

NCT ID NCT05791786

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating a registry and biorepository for people who have had a suspected amniotic fluid embolism (AFE), a rare and serious pregnancy complication. Researchers will collect medical information and biological samples from up to 400 participants, including mothers, their children, and family members. The goal is to better understand AFE and improve future care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMNIOTIC FLUID EMBOLISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

amniotic fluid embolism Embolism, Amniotic Fluid

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University of Texas Health Science Center at Houston

    RECRUITING

    Houston, Texas, 77030, United States